Short Interest in Aclarion, Inc. (NASDAQ:ACONW) Grows By 304.8%

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 2,445 shares, an increase of 304.8% from the May 31st total of 604 shares. Based on an average daily trading volume, of 7,826 shares, the short-interest ratio is currently 0.3 days.

Aclarion Trading Down 0.7%

Shares of Aclarion stock traded down $0.00 on Monday, reaching $0.03. The stock had a trading volume of 15,509 shares, compared to its average volume of 21,397. The business’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.04. Aclarion has a 1 year low of $0.02 and a 1 year high of $0.23.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.